CGRM Genetiko JSC
GECO.ME
Moscow Stock Exchange18.15
RUB
+0.20
- -
CGRM Genetiko JSC
GECO.ME
(Moscow Stock Exchange)
Recent
price
18.15
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- CGRM Genetico JSC (GECO.ME) operates as a medical genetics and reproductive medicine center, providing comprehensive genetic diagnostics, высокопроизводительное секвенирование, and related bioinformatics services within Russia, with headquarters in Moscow and a focus on Russian clientele. The company builds its offerings around genetic testing for inherited diseases, reproductive genetics, oncogenetics, and related diagnostic services, including noninvasive prenatal testing and sequencing of exomes/genomes, supported by a four-lab complex and bioinformatics pipelines; it participates in collaborations with leading sequencing and oncology partners to advance diagnostics and personalized medicine. Main products and services - Genetic diagnostics for hereditary diseases and reproductive health: clinical genetic testing, genetic counseling, interpretation of genomic data, and tailored diagnostic pathways. - Reproductive medicine genetics: preimplantation genetic testing (PGT) consultation, embryo-genetic screening, and diagnostic workflows for assisted reproduction. - Noninvasive prenatal testing (NIPT) and Prenetix NIPT services: screening for fetal chromosomal abnormalities during pregnancy. - DNA sequencing platforms: exome sequencing and whole-genome sequencing to identify pathogenic variants and assess hereditary risks. - Oncogenetics and tumor profiling: genetic testing of tumor tissue for mutations relevant to cancer diagnosis and treatment selection. - Genomic data analysis and bioinformatics: in-house pipelines for processing NGS data, interpretation frameworks, and software tools for variant analysis. - Laboratory services and diagnostics: a multi-lab operation including high-throughput sequencing, NIPT lab, oncogenetics lab, and genotyping lab offering end-to-end testing and reporting. Latest major company changes - Strategic partnerships and alliances: engages with leading industry players in sequencing and oncology to expand capabilities and access to international know-how; ongoing collaboration framework with technology and service partners to enhance test menus and data interpretation. - Funding, acquisitions, and corporate actions: listed on the Moscow Exchange under ticker GECO since 2023, reflecting a formal corporate structure and ongoing governance enhancements; alignment with investor relations programs and corporate actions for shareholders. - New products and service expansions: expansion of genetic testing panels to cover broader hereditary conditions and cancer-related mutations; enhancement of noninvasive prenatal testing offerings and developmental genomics services; ongoing development of bioinformatic platforms to improve interpretation accuracy and reporting speed. - Operational and geographic scope: primary operations conducted within Russia, with a focus on expanding service reach through presential clinics and collaboration with national partners; ongoing optimization of laboratory facilities and throughput capability to support increased testing volume. Additional context - Industry and segments: medical genetics, reproductive medicine, genomic diagnostics, oncology genetics, bioinformatics. - Target markets: healthcare providers, fertility clinics, hospitals, and directly referred patients within Russia. - Geographic operations: primarily Russia with emphasis on Moscow as headquarters; potential regional outreach through partner networks. - Founding year and headquarters: established in the early 2010s; headquartered in Moscow, Russia. - Subsidiaries and parent relationships: operates as a subsidiary structure under the larger Genetico healthcare and genetics ecosystem; relationships with partner laboratories and research institutes underpin service delivery.